In our patient with GDLD, a “c.355T > A” mutation in exon 1 of TACSTD2 was detected and believed to be responsible for the alteration of the amino acid leading to the formation of the amyloid deposits. This evidence concerns the gene TACSTD2 and gelatinous drop-like corneal dystrophy.